Skeletal Muscle of Stroke-Prone Spontaneously Hypertensive Rats Exhibits Reduced Insulin-Stimulated Glucose Transport and Elevated Levels of Caveolin and Flotillin

Diabetes

Volumn 50, Issue 9, 2001, Pages 2148-2156

  James, Declan J ^a   Cairns, Fiona ^a   Salt, Ian P ^a   Murphy, Gregory J ^b   Dominiczak, Anna F ^a   Connell, John M C ^a   Gould, Gwyn W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAV PROTEIN, RAT; CAVEOLIN; CAVEOLIN 1; FLOTILLINS; GLUCOSE TRANSPORTER; INSULIN; MEMBRANE PROTEIN;

ANIMAL; ARTICLE; CELL CULTURE; CEREBROVASCULAR ACCIDENT; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; RAT; SKELETAL MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; CAVEOLIN 1; CAVEOLINS; CELLS, CULTURED; CEREBROVASCULAR ACCIDENT; GENETIC PREDISPOSITION TO DISEASE; INSULIN; MALE; MEMBRANE PROTEINS; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE, SKELETAL; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0035464798     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.9.2148     Document Type: Article

References (55)

1. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. Reaven GM, Chang H, Hoffman BB, Azhar S: Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes 38:1155-1160, 1989
3. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J: Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21:76-83, 1999
4. Collison M, Glazier AM, Aitman TJ, Scott J, Graham D, Morton JJ, Dominiczak MH, Connell JMC, Gould GW, Dominiczak AF: Cd36 and molecular mechanisms on insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 49:2222-2226, 2000
5. James DE, Burleigh KM, Kraegen EW: In vivo glucose metabolism in individual tissues of the rat. J Biol Chem 261:6360-6374, 1986
6. Zorzano A, Munoz P, Camps M, Mora C, Testar X, Palacin M: Insulin-induced redistribution of GLUT4 glucose carriers in the muscle fiber: in search of GLUT4 trafficking pathways. Diabetes 45: S70-S81, 1996
7. Yeh JI, Gulve EA, Rameh L, Birnbaum MJ: The effects of wortmannin on rat skeletal muscle: dissociation of signalling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 270:2107-2111, 1995
8. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ: Evidence for 5′AMP-aetivated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47:1369-1373, 1998
9. Kurth-Kracznek EJ, Hirshmann MF, Goodyear LJ, Winder WW: 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48:1667-1671, 1999
10. Ploug T, van Deurs B, Ai H, Cushman SW, Ralston E: Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions. J Cell Biol 142:1429-1446, 1998
11. Aledo JC, Lavoie L, Volchuck A, Keller SR, Klip A, Hundal HS: Identification and characterization of two distinct intracellular GLUT4 pools in rat skeletal muscle: evidence for an endosomal and an insulin-sensitive GLUT4 compartment. Biochem J 325:727-732, 1997
12. Kahn BB, Rosen AS, Bak JF, Andersen PH, Damsbo P, Lund S, Pedersen O: Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors. J Clin Endocrinol Metab 74:1101-1109, 1992
13. Kahn BB: Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance. J Cell Biochem 48:122-128, 1992
14. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A: Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM and NIDDM. Diabetes 41:465-475, 1992
15. Garvey WT, Maianu L, Zhu J-H, Brechtel-Hook G, Wallace P, Baron AD: Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101:2377-2386, 1998
16. Goodyear LJ, Hirshman MF, Horton ES: Exercise-induced translocation of skeletal muscle glucose transporters. Am J Physiol 261:E795-E799, 1991
17. Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd P, Fisher EC, Wolfe RR, Elahi D, Evans WJ: Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 264: E855-E862, 1993
18. Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, Aronson D, Goodyear LJ, Horton ES: Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 48:1192-1197, 1999
19. Wojtaszewski JFP, Hansen BF, Gade J, Kiens B, Markuns JF, Goodyear LJ, Richter EA: Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 49:325-331, 2000
20. Maier V, Melvin DR, Lister CA, Chapman H, Gould GW, Murphy GJ: v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats. Diabetes 49:618-625, 2000
21. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR: CAP defines a second insulin signalling pathway required for insulin-stimulated glucose transport. Nature 407: 202-207, 2000
22. Mastick CC, Brady MJ, Saltiel AR: Insulin stimulates the tyrosine phosphorylation of caveolin. J Cell Biol 129:1523-1531, 1995
23. Mastick CC, Saltiel AR: Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 adipocytes. J Biol Chem 272:20706-20714, 1997
24. Millar CA, Sherwan A, Hickson GRX, James DE, Gould GW: Differential regulation of secretory compartments containing the insulin-responsive glucose transporter, GLUT4, in 3T3-L1 adipocytes. Mol Biol Cell 10:3675-3688, 1999
25. Salt IP, Connell JMC, Gould GW: 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49:1649-1656, 2000
26. Tellam JT, Macaulay SL, McIntosh S, Hewish DR, Ward CW, James DE: Characterization of Munc-18c and syntaxin-4 in 3T3-L1 adipocytes: putative role in insulin-dependent movement of GLUT-4. J Biol Chem 272: 6179-6180, 1997
27. Woods A, Salt IP, Scott JD, Hardie DG, Carling D: The α1 and α2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397:347-351, 1996
28. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Gauguier D, Reid JL, Macrae IM, Dominiczak AF: Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 16:364-367, 1997
29. Sarabia V, Lam L, Burdett E, Leiter LA, Klip A: Glucose transport in human skeletal muscle cells in culture: stimulation by insulin and metformin. J Clin Invest 90:1386-1395, 1992
30. Clark SF, Martin S, Carozzi AJ, Hill MM, James DE: Intracellular localisation of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton. J Cell Biol 140:1211-1225, 1998
31. Clark SF, Molero JC, James DE: Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance. J Biol Chem 275:3819-3826, 2000
32. Whitehead JP, Clark SF, Urso B, James DE: Signalling through the insulin receptor. Curr Op Cell Biol 12:222-228, 2000
33. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA: Mechanism of activation of protein kinase B by insulin. EMBO J 15:6541-6551, 1996
34. Coffer PJ, Jin J, Woodgett JR: Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335:1-13, 1998
35. Foran PGP, Fletcher LM, Oatey PB, Mohammed N, Dolly JO, Tavaré JM: Protein kinase B stimulates the translocation of GLUT4 but not GLUT1 or transferrin receptors in 3T3-L1 adipocytes by a pathway involving SNAP-23, synaptobrevin-2, and/or cellubrevin. J Biol Chem 274:28087-28095, 1999
36. Hill MM, Clark SF, Tucker DF, Birnbaum MJ, James DE, Macaulay SL: A role for protein kinase B/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol Cell Biol 19:7771-7781, 1999
37. Wang O, Somwar R, Bilan PJ, Liu Z, Jin J, Wwoodgett JR, Klip A: Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 19:4008-4018, 1999
38. Rea S, James DE: Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 46:1667-1677, 1997
39. Cheung PCF, Salt IP, Davies SP, Hardie DG, Carling D: Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem J 346:659-669, 2000
40. Houmard JA, Hickey MS, Tyndall GL, Gavigan KE, Dohm GL: Seven days of exercise increase GLUT-4 protein content in human skeletal muscle. J Appl Physiol 79:1936-1938, 1995
41. Yip J, Facchini FS, Reaven GM: Resistance to insulin-mediated glucose disposal as a predicator of cardiovascular disease. J Clin Endocrinol Metab 83:2773-2776, 1998
42. Laasko M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937-942, 1999
43. White MF, Kahn CR: The insulin signalling system. J Biol Chem 269:1-4, 1994
44. Inoue G, Cheatham B, Emkey R, Kahn CR: Dynamics of insulin signalling in 3T3-L1 adipocytes. J Biol Chem 273:11548-11555, 1998
45. Pessin JE, Thurmond DC, Elmendorf JS, Coker KJ, Okada S: Molecular basis of insulin stimulated GLUT4 vesicle trafficking: location! location! location! J Biol Chem 274: 2593-2596, 1999
46. Martin L, Shewan A, Millar CA, Gould GW, James DE: Vesicle associated membrane protein-2 (VAMP2) plays a specific role in the insulin-dependent trafficking of the facultative glucose transporter GLUT4 in 3T3-L1 adipocytes. J Biol Chem 273:1444-1452, 1998
47. Martin S, Tellam J, Livingstone C, Slot JW, Gould GW, James DE: The glucose transporter (GLUT4) and vesicle-associated membrane protein (VAMP2) are segregated from recycling endosomes in insulin-sensitive cells. J Cell Biol 134:625-635, 1996
48. Volchuk A, Wang Q, Ewart HS, Liu Z, He L, Bennett MK, Klip A: Syntaxin 4 in 3T3-L1 adipocytes: regulation by insulin and participation in insulin-dependent glucose transport. Mol Biol Cell 7:1075-1082, 1996
49. Volchuk A, Mitsumoto Y, He L, Lui Z, Habermann E, Trimble WS, Klip A: Expression of vesicle-associated membrane protein 2 (VAMP2)/synaptobrevin II and cellubrevin in rat skeletal muscle and in a muscle cell line. Biochem J 304:139-145, 1994
50. Olson AL, Knight JB, Pessin JE: Syntaxin 4, VAMP2, and/or VAMP3/Cellubrevin are functional target membrane and vesicle SNAP receptors for insulin-stimulated GLUT4 translocation in adipocytes. Mol Cell Biol 17:2425-2435, 1997
51. Cheatham B, Volchuk A, Kahn CR, Wang L, Rhodes C, Klip A: Insulin-stimulated translocation of GLUT4 glucose transporters requires SNARE-complex proteins. Proc Natl Acad Sci USA 93:15169-15173, 1996
52. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP: Caveolins, liquid-ordered domains and signal transduction. Mol Cell Biol 19:7289-7304, 1999
53. Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, Lindroth M, Peterson KH, Magnusson K-E, Strålfors P: Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 13:1961-1971, 1899
54. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF: Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol 127:1233-1243, 1994
55. Saltiel AR: Diverse signaling pathways in the cellular actions of insulin. Am J Physiol 270:E375-E385, 1996.